← Leaderboards
Katherine S Bowdish
Alexion Pharmaceuticals, Inc.
$2,559,731
Attributed
$2,559,731
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–06$2M$1.5M$1M$500K$0
'05
'06
Funding mix
By agency
NIH$2,559,731 · 1
By mechanism
U01$2,559,731 · 1
Top collaborators
No co-investigators on record.
Most similar at Alexion Pharmaceuticals, Inc.
Same institution · by research overlap
- Yi None Wang$692,000
Others in their field
Top investigators on “Immunologic Substance Development /Preparation”
- Maureen Howard · Chemocentryx, Inc.$7,605,790
- Israel Lowy · Medarex, Inc.$6,431,762
- Arthur M. Krieg · University Of Pennsylvania$6,250,700
- William C Olson · Progenics Pharmaceuticals, Inc.$5,661,660
- Vincent Strout · Elusys Therapeutics, Inc.$5,000,000
- Susan B Zolla-Pazner · New York University School Of Medicine$3,671,666
Research focus
Immunologic Substance Development /PreparationMonoclonal AntibodyDrug Screening /EvaluationBioterrorism /Chemical WarfareClinical ResearchCooperative StudyDosageDrug Administration RoutesHuman SubjectLaboratory RabbitMacaca FascicularisMilitary PersonnelPhage DisplayAnthraxPharmacokineticsAntibacterial AntibodyBacillus AnthracisBiotechnology